Zhejiang Sunflower Light Energy

SHE:300111 China Drug Manufacturers - Specialty & Generic
Market Cap
$742.09 Million
CN¥5.44 Billion CNY
Market Cap Rank
#10088 Global
#2170 in China
Share Price
CN¥4.23
Change (1 day)
-1.86%
52-Week Range
CN¥2.44 - CN¥9.43
All Time High
CN¥9.43
About

Zhejiang Sunflower Great Health Co., Ltd. engages in the research, development, production, and sale of anti-infectious, cardiovascular, digestive system and other drugs in China and internationally. It offers clarithromycin API and tablets, anti-infective drugs used for nasopharyngeal infection, lower respiratory tract infection, skin and soft tissue infection, acute otitis media, Mycoplasma pne… Read more

Zhejiang Sunflower Light Energy (300111) - Net Assets

Latest net assets as of September 2025: CN¥826.15 Million CNY

Based on the latest financial reports, Zhejiang Sunflower Light Energy (300111) has net assets worth CN¥826.15 Million CNY as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥969.22 Million) and total liabilities (CN¥143.08 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥826.15 Million
% of Total Assets 85.24%
Annual Growth Rate 12.98%
5-Year Change 203.62%
10-Year Change -34.98%
Growth Volatility 84.11

Zhejiang Sunflower Light Energy - Net Assets Trend (2007–2024)

This chart illustrates how Zhejiang Sunflower Light Energy's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Zhejiang Sunflower Light Energy (2007–2024)

The table below shows the annual net assets of Zhejiang Sunflower Light Energy from 2007 to 2024.

Year Net Assets Change
2024-12-31 CN¥822.98 Million +1.66%
2023-12-31 CN¥809.53 Million +95.14%
2022-12-31 CN¥414.84 Million +1.12%
2021-12-31 CN¥410.25 Million +51.35%
2020-12-31 CN¥271.06 Million +57.82%
2019-12-31 CN¥171.75 Million -3.06%
2018-12-31 CN¥177.16 Million -86.51%
2017-12-31 CN¥1.31 Billion +0.94%
2016-12-31 CN¥1.30 Billion +2.76%
2015-12-31 CN¥1.27 Billion +4.77%
2014-12-31 CN¥1.21 Billion +4.09%
2013-12-31 CN¥1.16 Billion +2.96%
2012-12-31 CN¥1.13 Billion -24.32%
2011-12-31 CN¥1.49 Billion -10.20%
2010-12-31 CN¥1.66 Billion +169.03%
2009-12-31 CN¥616.58 Million +50.40%
2008-12-31 CN¥409.97 Million +296.83%
2007-12-31 CN¥103.31 Million --

Equity Component Analysis

This analysis shows how different components contribute to Zhejiang Sunflower Light Energy's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 11827.3% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock CN¥1.29 Billion 187.57%
Other Comprehensive Income CN¥94.66 Million 13.79%
Other Components CN¥508.89 Million 74.16%
Total Equity CN¥686.24 Million 100.00%

Zhejiang Sunflower Light Energy Competitors by Market Cap

The table below lists competitors of Zhejiang Sunflower Light Energy ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Zhejiang Sunflower Light Energy's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 678,325,719 to 686,244,996, a change of 7,919,277 (1.2%).
  • Net income of 7,827,256 contributed positively to equity growth.
  • Dividend payments of 1,091,721 reduced retained earnings.
  • Other comprehensive income increased equity by 102,099,457.
  • Other factors decreased equity by 100,915,715.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income CN¥7.83 Million +1.14%
Dividends Paid CN¥1.09 Million -0.16%
Other Comprehensive Income CN¥102.10 Million +14.88%
Other Changes CN¥-100.92 Million -14.71%
Total Change CN¥- 1.17%

Book Value vs Market Value Analysis

This analysis compares Zhejiang Sunflower Light Energy's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 8.04x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has increased from 6.13x to 8.04x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2007-12-31 CN¥0.69 CN¥4.23 x
2008-12-31 CN¥0.57 CN¥4.23 x
2009-12-31 CN¥0.65 CN¥4.23 x
2010-12-31 CN¥1.59 CN¥4.23 x
2011-12-31 CN¥1.36 CN¥4.23 x
2012-12-31 CN¥1.01 CN¥4.23 x
2013-12-31 CN¥1.14 CN¥4.23 x
2014-12-31 CN¥0.97 CN¥4.23 x
2015-12-31 CN¥1.16 CN¥4.23 x
2016-12-31 CN¥1.27 CN¥4.23 x
2017-12-31 CN¥1.11 CN¥4.23 x
2018-12-31 CN¥0.18 CN¥4.23 x
2019-12-31 CN¥0.04 CN¥4.23 x
2020-12-31 CN¥0.13 CN¥4.23 x
2021-12-31 CN¥0.26 CN¥4.23 x
2022-12-31 CN¥0.26 CN¥4.23 x
2023-12-31 CN¥0.53 CN¥4.23 x
2024-12-31 CN¥0.53 CN¥4.23 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Zhejiang Sunflower Light Energy utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 1.14%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 2.37%
  • • Asset Turnover: 0.33x
  • • Equity Multiplier: 1.46x
  • Recent ROE (1.14%) is above the historical average (-38.26%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2007 10.54% 3.23% 0.61x 5.37x CN¥557.31K
2008 18.28% 6.90% 0.68x 3.91x CN¥33.93 Million
2009 16.76% 10.16% 0.53x 3.11x CN¥41.68 Million
2010 15.15% 10.79% 0.83x 1.69x CN¥85.43 Million
2011 2.34% 1.80% 0.55x 2.38x CN¥-114.12 Million
2012 -31.70% -29.14% 0.40x 2.70x CN¥-469.92 Million
2013 3.50% 3.62% 0.39x 2.48x CN¥-75.42 Million
2014 3.10% 2.28% 0.52x 2.61x CN¥-83.31 Million
2015 6.93% 4.80% 0.59x 2.43x CN¥-38.91 Million
2016 2.36% 1.91% 0.57x 2.16x CN¥-99.42 Million
2017 1.80% 1.55% 0.57x 2.05x CN¥-107.70 Million
2018 -569.23% -124.94% 0.62x 7.37x CN¥-1.14 Billion
2019 -228.28% -13.74% 1.21x 13.79x CN¥-119.96 Million
2020 37.20% 19.47% 0.51x 3.76x CN¥40.85 Million
2021 18.62% 17.97% 0.47x 2.20x CN¥24.73 Million
2022 -0.40% -0.34% 0.55x 2.16x CN¥-29.72 Million
2023 3.21% 6.43% 0.27x 1.83x CN¥-46.08 Million
2024 1.14% 2.37% 0.33x 1.46x CN¥-60.80 Million

Industry Comparison

This section compares Zhejiang Sunflower Light Energy's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $2,123,990,643
  • Average return on equity (ROE) among peers: -0.22%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Zhejiang Sunflower Light Energy (300111) CN¥826.15 Million 10.54% 0.17x $519.61 Million
Shenzhen Neptunus Bioengineering Co Ltd (000078) $6.47 Billion 9.88% 3.77x $616.08 Million
Anhui Fengyuan Pharmaceutical Co Ltd (000153) $1.18 Billion 2.74% 0.95x $320.56 Million
Shan Dong Dong-E E-Jiao Co Ltd (000423) $10.33 Billion 15.07% 0.27x $3.03 Billion
Wedge Industrial Co Ltd (000534) $298.72 Million 1.96% 0.38x $1.77 Billion
Yunnan Baiyao Group Co Ltd (000538) $35.11 Million 18.13% 0.80x $5.62 Billion
Hainan Haiyao Co Ltd (000566) $353.98 Million -9.58% 0.80x $702.18 Million
Tus Pharmaceutical Group Co Ltd (000590) $269.51 Million -61.02% 1.05x $317.08 Million
Northeast Pharmaceutical Group Co Ltd (000597) $927.49 Million 2.65% 1.38x $425.60 Million
Jilin Aodong Pharmaceutical Group Co Ltd (000623) $1.11 Billion 7.32% 0.29x $2.05 Billion
Renhe Pharmacy Co Ltd (000650) $261.49 Million 10.60% 0.82x $777.45 Million